Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Proliferation indices in malignant lymphomas.

¹Department of Histopathology, East Birmingham Hospital, England.

Clinical and Experimental Immunology

|September 1, 1989

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Coexistence of cluster spin glass and superconductivity in Ba(Fe(1-x)Co(x))2As2 for 0.060≤x≤0.071.

Physical review letters·2013

Same author

The presence of radiological features on chest radiographs: how well do clinicians agree?

Clinical radiology·2012

Same author

Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2009

Same author

Solitary ovarian splenosis.

Journal of clinical pathology·2005

Same author

Neuropsychological functioning in end-stage renal disease.

Archives of disease in childhood·2004

Same author

Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.

Proceedings of the National Academy of Sciences of the United States of America·2004

Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026

Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026

Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026

Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026

Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026

Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026

See all related articles

Assessing proliferation rates is crucial for tailoring therapy in malignant lymphomas. Various techniques, including DNA flow cytometry and antibody-based methods, have evolved for evaluating tumor growth and patient prognosis.

Area of Science:

Oncology
Hematology
Cell Biology

Background:

Malignant lymphomas require tailored therapy based on prognostic groups.
Accurate assessment of tumor proliferation is essential for effective treatment strategies.

Purpose of the Study:

To review the evolution of methods used to assess proliferation rates in malignant lymphomas.
To evaluate the usefulness of different proliferation assessment techniques.

Main Methods:

Review of techniques including radiolabelled thymidine uptake.
Analysis of DNA flow cytometry.
Application of antibodies to proliferation-associated antigens.
Enumeration of nucleolar organizer regions.

Main Results:

Related Experiment Videos

Multiple techniques for assessing proliferation have been developed over two decades.
These methods aim to improve prognostic group classification for lymphomas.

Conclusions:

The evolution of proliferation assessment techniques offers improved tools for lymphoma management.
Evaluating the usefulness of these methods is key to optimizing patient therapy.